Xavier Durando

Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer

Mathilde Bayet‐Robert, Fabrice Kwiatowski, Marianne Leheurteur et al. · Cancer Biology & Therapy · 2010 · 386 citations · Full text

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study

Shubham Pant, Martin Schüler, Gopa Iyer et al. · The Lancet Oncology · 2023 · 175 citations · Full text

Fgfr Alterations, Medicine, Pathology +7

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial

Serge Leyvraz, Sophie Piperno‐Neumann, Stefan Suciu et al. · Annals of Oncology · 2014 · 142 citations · Full text

Surgical Oncology, Hepatology, Ophthalmology +12

The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study

Hakim Mahammedi, E. Planchat, Mélanie Pouget et al. · Oncology · 2016 · 135 citations

Prediction of overall survival through circadian rest‐activity monitoring during chemotherapy for metastatic colorectal cancer

Pasquale F. Innominato, Sylvie Giacchetti, Georg A. Bjarnason et al. · International Journal of Cancer · 2012 · 128 citations · Full text